JNJ — JOHNSON & JOHNSON
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 200406 ·
Last close
$239.08
Market Cap
$575.52B
52W High
$245.80
52W Low
$219.11
ADV30
8,187,663
Next earnings
2026-07-15
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 24,062,000,000 | 15,956,000,000 | 6,395,000,000 | 5,235,000,000 | 200,894,000,000 | 21,688,000,000 | 119,708,000,000 |
| Dec 2025 | 24,564,000,000 | 16,596,000,000 | 5,591,000,000 | 5,116,000,000 | 199,210,000,000 | 19,709,000,000 | 117,666,000,000 |
| Sep 2025 | 23,993,000,000 | 16,690,000,000 | 7,096,000,000 | 5,152,000,000 | 192,816,000,000 | 18,231,000,000 | 113,539,000,000 |
| Jun 2025 | 23,743,000,000 | 16,115,000,000 | 6,710,000,000 | 5,537,000,000 | 193,389,000,000 | 18,577,000,000 | 114,916,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,870,000,000
Investing CF
$-24,331,000,000
Financing CF
$-15,431,000,000
CapEx
$-5,457,000,000
Dividends Paid
$-12,523,000,000
Buybacks
$-7,854,000,000
EPS Diluted TTM
$8.65
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
$14,583,000,000
Receivables
$22,539,000,000
ST Investments
$363,000,000
EBIT TTM
$25,979,000,000
Pretax Income TTM
$24,940,000,000
Interest Exp TTM
$1,039,000,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$96,361,996,288
EBITDA
$34,325,000,192
Free Cash Flow
$12,511,375,360
Enterprise Value
$608,453,459,968
Total Cash
$22,051,000,320
Total Debt
$54,987,001,856
Shares Out
2,407,216,971
Trailing EPS
$8.63
Book Value
$33.73
ROE
26.4%
ROA
8.4%
Div Yield
2.24%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 94,193,000,000 | 25,596,000,000 | 26,804,000,000 | 199,210,000,000 | 117,666,000,000 | — | 24,530,000,000 |
| Dec 2024 | 88,821,000,000 | 21,249,000,000 | 14,066,000,000 | 180,104,000,000 | 108,614,000,000 | — | 24,266,000,000 |
| Dec 2023 | 85,159,000,000 | 22,009,000,000 | 35,153,000,000 | 167,558,000,000 | 98,784,000,000 | — | 22,791,000,000 |
| Dec 2022 | 79,990,000,000 | 21,013,000,000 | 17,941,000,000 | 187,378,000,000 | 110,574,000,000 | — | 21,194,000,000 |
TTM Snapshot
Revenues TTM
$87,156,000,000
NetIncome TTM
$36,847,000,000
OpCashFlow TTM
$0
Assets (Latest)
$180,104,000,000
Forward EPS
$12.70
Max Pain — expiry 2026-06-26
max pain strike: $232.50 · spot: $241.00 · call oi: 7,572 · put oi: 5,631
Expected Move to 2026-06-26:
±$4.02
(1.67%) —
implied range
$236.97 –
$245.03
· ATM straddle on $240.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABBV | AbbVie Inc. | $414.77B | $234.76 | — |
| LLY | ELI LILLY & Co | $987.23B | $1107.08 | — |
| NVSEF | NOVARTIS AG | $298.90B | $156.65 | — |
| MRK | Merck & Co., Inc. | $295.39B | $119.60 | — |
| NVS | NOVARTIS AG | $292.66B | $153.38 | — |
News headlines (Yahoo Finance, 1h cache)
SNPD ETF Targets Next Dividend Aristocrats With 10-year Growth Screen
2026-06-24 20:02 · Yahoo
The Number That Could Test AbbVie Stock
2026-06-24 19:32 · Yahoo
Equal Weighted Dividends Across 54 Stocks Deliver 24.7% Returns and Growing Payouts
2026-06-24 19:00 · Yahoo
J&J CEO sends a clear message on the obesity drug boom
2026-06-24 18:47 · Yahoo
The Retirement Portfolio for Grandparents Who Want to Say Yes
2026-06-24 17:22 · Yahoo
Alphabet makes the Dow look more like the Nasdaq
2026-06-24 15:52 · Yahoo
The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari
2026-06-24 15:38 · Yahoo
3 Quality Dividend Aristocrats to Buy in June
2026-06-24 14:54 · Yahoo
The Portfolio That Quietly Pays For Two Cruises Every Year
2026-06-24 13:27 · Yahoo
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching
2026-06-24 11:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.